A primary or metastatic malignant neoplasm affecting the brain.
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning brain cancer
Updated Feb 3, 2026
The UK government will integrate the 'Be part of research' service into the NHS App, allowing patients with rare cancers to register for clinical trials. This initiative aims to enhance awareness and inclusivity in clinical research, particularly for brain cancers and other rare diseases.
Patients with rare cancers, particularly aggressive brain cancers, will gain faster access to breakthrough treatments due to new initiatives aimed at transforming clinical trial access. This change is expected to enhance treatment options for these hard-to-treat conditions.
A new observational study sponsored by the National Cancer Institute aims to evaluate treatment responses in patients with advanced central nervous system tumors, including various types of gliomas. The study is currently not yet recruiting participants.